A
ANTX
AN2 Therapeutics, Inc.
5.78
-0.01-0.17%Opening14:08 08/21 EDT
OPEN/PREV CLOSE5.84/5.79
TODAY RANGE5.50-5.89
VOL100.70K
MARKET CAP218.12M
52 WEEK RANGE1.000-7.19
AVG VOL (3M)296.43K
% TURNOVER0.27%
TURNOVER--
P/E (TTM)-5.3863
% RANGE6.74%
EPS(TTM)-1.0731
P/E(FORWARD)-6.7209
P/B2.764
BVPS2.091
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP177.99M
SHARES OUTSTANDING37.74M
NEXT EARNINGS11/10-11/16
FREE FLOAT30.79M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/11 20:06
AN2 Therapeutics reports Q2 EPS (18c), two estimates (24c)
Seeking Alpha·07/20 14:31
Anterix stock climbs to all-time high as year-to-date gains near 400%
TipRanks·07/20 00:50
AN2 Therapeutics initiated with a Buy at Guggenheim
TipRanks·07/17 12:35
One new option listing on July 17th
TipRanks·06/09 10:45
AN2 Therapeutics Holds 2026 Annual Stockholder Meeting
TipRanks·06/04 21:57
AN2 Therapeutics Advances Chagas Candidate After Positive Trials
Seeking Alpha·06/04 12:21
AN2 rises after early-stage trial data for Chagas disease therapy
TipRanks·06/04 11:18
AN2 Therapeutics reports data from two studies of AN2-502998 in Chagas disease
TipRanks·05/14 10:33
AN2 Therapeutics upgraded to Outperform from Market Perform at Leerink
TipRanks·05/11 21:38
AN2 Therapeutics reports Q1 EPS (29c), one estimate (23c)
Seeking Alpha·05/11 20:54
AN2 Therapeutics GAAP EPS of -$0.29 misses by $0.06
TipRanks·04/09 21:34
AN2 Therapeutics Launches New $80 Million ATM Program
TipRanks·04/09 21:25
AN2 Therapeutics files $300M mixed securities shelf
Same Industry
Name/Symbol
Change%
Price